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Abstract
The public health care systems in the Nordic countries provide high
quality care almost free of charge to all citizens. However, social inequal-
ities in health persist. Previous research has, for example, documented
substantial educational inequalities in cancer survival. We investigate to
what extent this may be driven by diﬀerential access to and utilization of
high quality treatment options. Quasi-experimental evidence based on the
establishment of regional cancer wards indicates that i) highly educated
individuals utilized centralized specialized treatment to a greater extent
than less educated patients and ii) the use of such treatment improved
these patients' survival.
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1 Introduction
Educational inequalities in mortality rates have been documented across a wide
range of countries. Diﬀerences in lifestyle and health behaviors are major factors
driving the positive association between education and health, but the quality
of treatment for various diseases could also play a role. Treatment quality is
expected to depend on income when health services must be bought in the
open market, such as in the United States. This is less obvious in egalitarian
welfare states such as the Nordic countries, where public health care systems
aim to oﬀer equal access to high quality health care, regardless of socioeconomic
status and geographic location. This is particularly true for cancer diagnosis,
treatment, and care, where private options are virtually nonexistent. Against
this background, it is surprising that educational inequalities in cancer mortality
are of a similar magnitude in the United States and in the Nordic countries (cp.
Kinsey et al. 2008, Elstad et al. 2012).
A diﬀerence in economic resources is not the only possible mechanism behind
the relationship between education and health. Grossman (1972) emphasizes
that education may aﬀect health directly, acting as a 'technology parameter' in
a health production function (Cutler and Lleras-Muney 2012). Highly educated
individuals may make more eﬃcient use of available health inputs for various
reasons. People with higher education could, for example, have a better un-
derstanding of the relationship between health inputs (behavior and treatment)
and health outcomes (Kenkel 1991). Glied and Lleras-Muney (2008) ﬁnd that
better educated individuals have a greater survival advantage from diseases for
which there has been rapid health-related technological progress. This indicates
that people with higher education are the ﬁrst to take advantage of technological
advances that improve health.
A related hypothesis is that highly educated people may be better at ﬁnd-
ing their way through the health bureaucracy, claiming their rights, acquiring
relevant information, and communicating their symptoms. Several studies show
that patient-provider communication varies with patients' socioeconomic sta-
tus, with the level of education being of particular importance (e.g., Smith et
al. 2009, Marks et al. 2010, Grytten et al. 2011). Bago d'Uva and Jones (2009)
document that highly educated individuals use specialist care more frequently
in many European countries, irrespective of actual needs.
In this paper, we investigate how access to and utilization of highly spe-
cialized treatment aﬀects survival after cancer, and how this is related to edu-
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cational attainment. We use individual level data covering all primary cancer
diagnoses in Norway from 1980 to 2000. During this period, patients were al-
located to local hospitals based on their residential addresses, and they were
only transferred to other hospitals if specialized treatment was deemed neces-
sary. Typically, patients would be transferred to the national hospitals located
in Oslo for specialized treatment (Kravdal 2006).1 However, patient-doctor in-
teractions could also play a role since referral practices and treatment protocols
are not fully codiﬁed. In our analysis, being treated in the health region where
the national hospitals are located is a proxy for specialized treatment. To ana-
lyze how specialized treatment aﬀects survival probabilities, we make use of the
fact that regional cancer wards opened at diﬀerent points in time in cities with
universities outside the Oslo area.
Several studies document that there are fewer complications and improved
survival chances at more specialized centers (for example, Black and Johnston
1990, Kelly and Hellinger 1986). Hospital volume and surgeon competency
have been shown to be particularly important (Porter et al. 1998, Wibe et al.
2005). In our context, the care provided in the newly opened regional cancer
wards could therefore have been of lower quality than the care provided at the
well-established national hospitals, especially in the period shortly after their
establishment. The opening of the new wards can therefore be interpreted as
representing a decrease in access to specialized treatment for patients residing
in these regions. The opening of the regional wards and the subsequent build-
up of local knowledge and expertise meant that transferring patient groups
with common cancer forms between health regions was no longer warranted.
The decentralization process was therefore accompanied by stricter regulations
concerning which cases should be treated centrally versus locally. As such, the
opening of regional wards meant that there was less scope for diﬀerences in
access to and the use of specialized treatment at the national hospitals that
were not directly related to disease characteristics.
We use the time variation in the establishment of the regional cancer wards
as a quasi-experiment providing exogenous variation in access to specialized
treatment. In a diﬀerences-in-diﬀerences framework, we thus exploit the sudden
fall in the transfer rate to the national hospitals in Oslo in two out of three health
regions (Central and Northern) to investigate how specialized treatment aﬀects
survival. The Western health region serves as the control group, as its transfer
1This is largely due to the availability of surgical equipment and expertise, but also because
of the absence of comprehensive oncology teams in regions outside the Oslo area.
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rate to Oslo was stable during the period under investigation. By applying a
diﬀerences-in-diﬀerences-in-diﬀerences set-up, we also investigate the extent to
which educational inequalities in cancer survival were aﬀected by the opening
of the regional cancer wards.
After controlling for the general time trend, we ﬁnd that survival rates de-
clined in regions where cancer wards were opened. The eﬀect was particularly
pronounced for patients living close to a newly established ward, and for patients
with university level education. This entails a reduction in educational inequal-
ities in cancer survival. Prior to the decentralization, patients with a university
level education were much more likely to be transferred to the national hospitals
than patients without such education. A plausible explanation for the drop in
the transfer probability diﬀerentials is that stricter transfer regulations made it
more diﬃcult to use a possible information or competency advantage to gain
access to specialized treatment. Our results thereby suggest that educational
inequalities may depend upon health sector organization. Our study also shows
that part of the educational gradient in cancer survival may be explained by
diﬀerent inputs (regional versus specialized care) having diﬀerent productivity,
and diﬀerential use of these inputs by educational attainment. The observed ed-
ucational gradient thus reﬂects more than just diﬀerences in unobserved patient
characteristics.
Our paper is related to the rapidly growing literature on the causal eﬀects
of education on health, typically using compulsory schooling laws as a source
of identiﬁcation. The results of these studies are, however, mixed. Lleras-
Muney (2005), who was the ﬁrst to make use of such laws in the US context,
ﬁnds a strong reduction in mortality for each year of additional schooling.2
This is in contrast to Clark and Royer (2013) and Meghir et al. (2012), who
fail to ﬁnd beneﬁcial eﬀects on health of compulsory schooling reforms in the
United Kingdom and Sweden.3 Our paper ﬁts with this literature by empirically
substantiating a plausible channel for the development of health disparities by
education.
2Later research has shown that this result is sensitive to the inclusion of state speciﬁc
trends (Mazumder 2008).
3Cutler and Lleras-Muney (2012) and Mazumder (2012) review this literature. Also the
content of education might matter for health outcomes. Leuven, Oosterbeek and Wolf (2013)
estimate the impact of attending medical school in the Netherlands. Using admission lotteries
for identiﬁcation they ﬁnd only modest impacts on health outcomes.
4
2 Institutional Setting
The public health care system in Norway oﬀers treatment, including highly spe-
cialized cancer care, universally and almost free of charge (Molven and Ferkis
2011). Moreover, it is based on the idea of decentralized authority, with clear
obligations for the diﬀerent actors involved. During our study period (1980-
2000), the municipalities (around 435 in total) had full responsibility for all pri-
mary and emergency health care for their residents, whereas more specialized
health care (including cancer care) was the responsibility of the counties (19 in
total).4 Through bilateral agreements, the counties collaborated to provide care
within ﬁve health regions. In addition, two national hospitals in the Oslo area
had a tertiary responsibility for providing state-of-the-art cancer treatment, and
challenging cases were thus transferred from counties and/or regions to these
institutions run by the central government. Thus, during our study period,
there were three levels of hospitals in Norway: Local hospitals (administrated
by individual counties), typically covering one or more municipalities; regional
hospitals (administrated by collaborating counties within the respective health
regions); and national hospitals (administrated by the central government). Pa-
tients were allocated to local and regional hospitals based on their residential
addresses.5
As of today, as shown in Figure 1, the municipalities are organized in four
health regions (South-Eastern; Western; Central; Northern).6 The national hos-
pitals, Rikshospitalet University Hospital and the Norwegian Radium Hospital,
are located in Oslo, the capital of Norway, in the South-Eastern health region.7
In the following, we refer to this region as the Oslo region.
The speed and quality of access to cancer care depends on referrals from
publicly employed general practitioners (GPs) working at the municipality level.
Some smaller municipalities have few, or even share GPs, whereas larger munic-
ipalities have several GPs. Although primary health care may be comprised of
many diﬀerent GPs, the municipalities have common guidelines for diagnostic
4Hospital ownership was transferred from the counties to the central government in 2002.
5Our register data allow us to follow patients up until the end of 2008. This means that we
can study ﬁve-year survival rates for patients diagnosed with cancer in 2003 at the latest. We
have therefore chosen to exclude data for the period after the system of free hospital choice
within care levels was introduced in 2001. Our main results are not altered in any substantial
way if we include also data through 2003.
6Five health regions existed up until 2002, after which two of them (Southern and Eastern)
merged. Our data follow the most recent health region structure.
7Today, they both belong to the Oslo University Hospital, along with other teaching hos-
pitals in the Oslo area.
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Figure 1: Norwegian municipalities and health regions
West
Oslo
Central
North
Oslo
Trondheim
Tromsø
(South/East)
Bergen
Note: The map shows the four health regions (marked by diﬀerent shades of
grey) and municipality borders based on the municipality structure of 2000
(n=435). The map also shows the cities of Oslo (where the two national hospitals
are located), Bergen (regional hospital with cancer ward since 1972), Trondheim
(regional hospital with cancer ward since 1987) and Tromsø (regional hospital
with cancer ward since 1985).
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work-up and referrals of persons who may have cancer.
The decision to either treat patients at the local hospitals (to which they
belong), or transfer them to more specialized care depended on an overall assess-
ment of patients' age, cancer form and spread, likely outcomes, and the availabil-
ity of specialized treatment, including surgical, radiation and chemotherapeutic
options within the local hospital catchment area. The patient's interaction with
the GP as well as with doctors at the local hospital is also likely to have played a
role for referrals and treatments, as there is room for judgement calls depending
on cancer type, likely outcomes, patient age etc.
As radiation treatment requires a series of treatments at designated hos-
pitals, it is the treatment form most strongly related to place of residence.
Closeness to a radiation unit strongly predicts its use (NOU 1997: 20). Until
the early 1970s, Oslo was the only health region that oﬀered adjuvant radiation
and chemotherapy.8 Hence, prior to the establishment of regional cancer wards
in 1972, 1985, and 1987 in the Western, Northern, and Central regions, respec-
tively, patients were required to travel to the Oslo region to obtain this type of
treatment.
Prior to the opening of the regional oncological wards, the standard practice
at local hospitals was to consult oncological surgeons at the Radium Hospital in
Oslo prior to diagnosis and treatment, as well as during the course of treatment.
The Radium Hospital was the primary oncological hospital in Norway prior to
the 1980s, and referrals were made almost exclusively to this hospital.9
Referral patterns changed after the opening of the regional oncological wards,
so that patients were primarily sent to these regional wards for diagnosis and,
when necessary, treatment. In cases where further treatment was deemed neces-
sary, referrals to the Radium Hospital were primarily initiated by these regional
oncological wards, typically after telephone consultations between the two. Af-
ter the opening of the regional wards, transfers of large patient groups with
8Surgical treatment, which has been available in Norway for more than 150 years, is
the primary treatment for most cancer forms. Patients may also be treated with radiation
(available in Oslo since the 1950s) and/or chemotherapy (available since the early 1970s).
According to a Norwegian Government White Paper from 1997 (NOU 1997: 20, Omsorg
og kunnskap!) around 85% of cured Norwegian patients received surgery. During the
period we study, radiation therapy was involved in around 40% of the cases, whereas
chemotherapeutic drugs were estimated to have been involved in around 14% of treatments
(http://www.helsetilsynet.no/upload/Publikasjoner/andrepublikasjoner/kapasitet_ventetid_straalebehandling_1999.pdf).
The use of radiation was limited until the late 1950s, but it gradually became more prevalent
in the 1960s and 1970s. Today, multimodal treatment regimens, i.e., various combinations of
surgery, radiation, and chemotherapy, predominate.
9Searches in newspaper archives indicate that doctors from the Northern health region
received training in Oslo prior to the opening of the regional wards.
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common cancer forms between regions was thus no longer warranted.10 By
the year 2000, comprehensive oncological teams comprising pathologists, radi-
ologists, oncologists, oncological surgeons, and other relevant health personnel
were present in all four health regions, and the regional hospitals in Bergen,
Tromsø and Trondheim were all incorporated in university settings.11
3 Data and Descriptive Statistics
Our analyses are based on individual level data from the Cancer Registry of
Norway matched with data on patients' level of education from administrative
registers from Statistics Norway. We distinguish between patients who have
university level education (higher education)12 and patients without a university
level education (lower education).
The Cancer Registry contains detailed information about the date of di-
agnosis, the patient's age at diagnosis, gender, tumor location (International
Classiﬁcation of Diseases, 10th revision (ICD-10)), stage at diagnosis (local, re-
gional, distant or unknown), residential municipality on the date of diagnosis,
and the health region the patient was treated and/or examined in.
We limit our sample to individuals residing outside the Oslo region who were
between 30 and 75 years old when ﬁrst diagnosed with cancer.13 This results
in 99,988 individuals in total, 10% of whom have a higher education. In our
10Due to a lack of information about patients' exact residential addresses and the treating
hospitals within the regions, we are unable to investigate transfers within health regions.
11National guidelines for the diagnosis and treatment of the most prevalent cancer forms
were introduced from the mid-1990s, and cancer care was gradually standardized and central-
ized within the respective health regions in order to ensure optimal treatment and outcomes
(see e.g., Wibe et al. (2003) and Kalager et al. (2009) for descriptions of surgical and onco-
logical management of colorectal and breast cancer, respectively). In practice, this resulted in
a substantial decline in the number of hospitals performing cancer surgery, from around 65 in
the late 1980s to around 20 in the late 1990s and the emergence of multidisciplinary oncology
teams providing high-quality care at designated regional hospitals. Throughout the period
assessed, guidelines have been in place that require specialized treatment at national hospitals
(also after the establishment of the regional cancer wards) for pediatric cancer patients and
young adult patients with fertility issues, as well as for patients with certain rare cancer forms.
This is to ensure that patients are handled by experienced medical personnel in units that are
familiar with relevant diagnostic and treatment protocols.
12This also includes education at university colleges.
13We restrict the analyses to individuals aged 30 years or older, because, at this age, most
individuals have completed their education and because cancer treatment for children and
young adults is largely centralized in Norway. We also exclude cancer patients who were older
than 75 years at diagnosis. Transfer and survival rates are low for this age group (1.38%
and 23.38%, respectively), and comorbid conditions must be taken into account in treatment
considerations. About 10% of all patients are diagnosed with more than one form of cancer.
We restrict the analyses to patients diagnosed with their ﬁrst cancer only.
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Figure 2: Proportion of cancer patients transferred to Oslo by health region and
county with university hospital
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Note: The ﬁgures display the transfer rate by health region (left panel) and
county with university hospital (right panel). Cancer wards were established at
the regional hospitals in Hordaland (West), Troms (North), and Sør-Trondelag
(Center), in 1972, 1985, and 1987, respectively. A patient is deﬁned as being
transferred if he/she was examined and/or received treatment in the Oslo region.
sample the median age at diagnosis is 64.
A descriptive overview of the variables used in this paper is provided in
Appendix Table A.1. The main outcome variable in our study is a dummy
variable equal to one if the patient is alive ﬁve years after diagnosis, and zero
otherwise (survival). A patient is assumed to receive high quality treatment
if she/he has been treated and/or examined in the Oslo region, where the two
national hospitals are located (referred to as transfer in the following).
3.1 Transfer and survival
The left panel of Figure 2 documents the extent of transfers from the Western,
Central and Northern regions to the Oslo region. The extent of transfers has
decreased over time for all health regions. These changes are mostly due to
university hospitals outside Oslo having become better equipped over time in
terms of personnel, laboratories, and surgical and radiological equipment. The
opening of a cancer ward in Trondheim in 1987 resulted in a drop in the trans-
fer probability from 0.25 in 1986 to 0.11 in 1988. Similarly, the opening of a
cancer ward in Tromsø in 1985 resulted in a more gradual drop in the transfer
probability from 0.37 in 1984 to 0.13 in 1989.14 For patients from the Western
14There is a slight reduction in the transfer rate in the Central region prior to the opening
of a regional cancer ward. This reﬂects the fact that a small proportion of patients received
treatment in the newly opened cancer ward in the Northern region in 1985-1986.
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Figure 3: Five-year survival rates by health region and county with university
hospital
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Note: The ﬁgures display the survival rate by health region (left panel) and
county with university hospital (right panel). Cancer wards were established at
the regional hospitals in Hordaland (West), Troms (North), and Sør-Trondelag
(Center), in 1972, 1985, and 1987, respectively. A patient is deﬁned as having
survived cancer if he/she is alive ﬁve years after cancer diagnosis.
health region, there was no substantial change in the transfer probability during
the 1980s. The university hospital in the Western health region opened a cancer
ward already in 1972, which was fully operational by 1976.
Because Norway is a outstretched country, traveling distances within health
regions are substantial for many patients. For example, the Northern region
covers an area that would take about 20 hours to drive across (about 1,000
miles).15 The traveling distance to the nearest cancer ward may be long even
after the establishment of regional cancer wards. Traveling by plane is therefore
an option that is likely to be utilized by many patients, and that could also aﬀect
the health authorities' decision whether or not to transfer patients to Oslo. The
right panel of Figure 2 shows transfer rates for the counties where the university
hospitals are located. The decline in transfer rates is more pronounced for this
sub-sample. This is reasonable, since traveling time was reduced most for this
group of patients.
The ﬁve-year all-cause survival rate following a cancer diagnosis increased
from 0.43 in 1980 to 0.59 in 2000. As documented in Figure 3, there are some
diﬀerences between the health regions.16 In the early 1980s, survival rates were
15According to Google Maps, the Central region, the Western region and the Oslo region
each cover an area that would take about 9 to 10 hours to drive across (about 350 to 450
miles).
16Although individuals living in the Oslo region are not included in the analyses, we include
the ﬁve-year survival rate for the Oslo region in Appendix Figure A.1 for comparison and
completeness purposes.
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very similar across all health regions, but the survival rate in Northern Norway
started to lag behind from about 1985. This coincided with the opening of the
cancer ward in Tromsø. The same pattern is also evident when the analysis is
limited to patients residing in the counties where the university hospitals are
located (right panel of Figure 3).
As cancer is a serious disease, local physicians are generally quick to refer
patients with a suspected malignancy to an appropriate diagnostic work-up.
Such work-ups have been available at hospitals at all levels (i.e., local, regional,
and national) throughout the period we have studied. It has been possible
for local hospitals without their own laboratories to send specimens to either
private laboratories or laboratories at larger hospitals for the necessary analyses.
It is therefore not surprising that the opening of regional cancer wards did not
have a signiﬁcant impact on the number of patients diagnosed with cancer or a
diﬀerential impact on the respective cancer incidences. Over the period studied,
there has been an increase in the number of cancer incidences in all regions, but
the changes have been similar and unrelated to the cancer ward openings, as can
be seen from Figure 4.17 Stage at diagnosis also shows a similar development
in the Western, Central and Northern regions (see Figure 5). The pronounced
change in the number of cancer cases with unknown stage is the result of changes
in the coding practice at the Cancer Registry of Norway in the mid-1980s.18
3.2 Educational inequalities in transfer and survival
Treatment in the Oslo region and cancer survival are both strongly related to
the patients' level of education. In columns (1) and (2) of Table 1, we present
results from regressing patients' level of education on transfer and survival using
a linear probability model for the whole study period. The results for transfer
are reported in the upper panel of the table, whereas the results for survival
are reported in the lower panel.19 The probability of being transferred to the
Oslo region is 1.4 percentage points higher for patients with a higher education
relative to those with a lower education. The eﬀect is statistically signiﬁcant at
17Neither did the opening of regional cancer wards signiﬁcantly impact on the number of
cancer patients in the Oslo region (see Appendix Figure A.2).
18Unless it was positively conﬁrmed that there was no distant spread, cases were from
this point onwards coded as having an unknown spread whereas such cases were previously
assigned a stage based on their reported degree of spread, locally or regionally. Before the
mid-1980s it was thus assumed that, if no distant spread was noted, there was none.
19Since all our control variables are discrete, we estimate linear probability models (as
recommended by, for example, Angrist 2001).
11
Figure 4: Number of incident cancers by health region
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Figure 5: Stage at diagnosis by health region
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Note: The ﬁgures displays the fraction of patients with localized, regional, dis-
tant, and unknown spread, by time of diagnosis and health region.
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Figure 6: Diﬀerences across educational disciplines in patients with higher edu-
cation
Medicine
Law
Health Sciences
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Business
Natural Sciences
−.1 −.05 0 .05 .1
Transfer Probability
Medicine
Law
Health Sciences
Hum. and Soc. Sciences
Business
Natural Sciences
−.1 −.05 0 .05 .1
Survival Probability
Note: Estimates and corresponding 95% conﬁdence intervals from linear prob-
ability models are reported. The sample is limited to patients with a university
level education (n=9,999). Patients educated as teachers comprise the reference
group. Time ﬁxed eﬀects, county ﬁxed eﬀects and a full battery of patient and
disease characteristics are included. Standard errors are heteroscedastic robust
and corrected for clustering at the (residential) municipality level at the time of
diagnosis. The mean for survival is 0.65. The mean for transfer is 0.12.
the one percent level. Individuals with a higher education are also more likely
to survive cancer. This result has previously been documented for Norway and
other countries (see, for example, Kravdal 2000, Du et al. 2006, Lang et al.
2009, Fiva, Hægeland and Rønning 2010, Kravdal and Syse 2011).
Cancer covers many diagnoses that diﬀer greatly with respect to severity and
treatability. When controlling for disease characteristics such as cancer type and
stage at diagnosis (column (2)), the model improves considerably (the R-square
roughly doubles), and the association between level of education and transfer
probability increases to 2.6 percentage points. This indicates that patients with
a university level education tend to be less in need of specialized care at national
hospitals. This is consistent with previous studies that have documented that
people with higher education are more likely to be diagnosed at an earlier stage
(Clegg et al. 2009). The eﬀect of education on survival, on the other hand,
decreases when disease controls are added. Part of the (unadjusted) educational
inequality in cancer survival is therefore due to diﬀerences in disease severity.
We also relate the probability of transfer and survival, respectively, to pa-
tients' type of education. The left panel of Figure 6 shows that being educated
as a doctor increases the probability of being transferred to Oslo by about ﬁve
percentage points relative to those educated as teachers (the reference group).
This is an increase of around 40% in the transfer probability relative to the base-
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line transfer rate (13%). Doctors also have about a ﬁve percentage points higher
probability of surviving cancer. Lawyers and other health care professionals also
have a statistically signiﬁcant higher probability of receiving treatment in Oslo,
but this does not manifest itself in a higher survival probability for these groups.
Estimates reported in Figure 6 are from speciﬁcations that include a full
battery of patient and disease characteristics. Together with the diﬀerences with
respect to level of education, these ﬁndings indicate that, even in an egalitarian
welfare state, access to treatment appears to depend on socioeconomic status.
Highly educated and better informed patients appear to receive better treatment
than others.
3.3 Regional cancer wards and educational inequalities in
transfer and survival
In columns (3)-(8) of Table 1, we show separate results for educational inequal-
ities for each health region.20 We examine the periods before and after the
opening of the regional cancer wards separately (henceforth the pre and post.21
During the pre-reform period in the Central region, the probability of being
transferred was 4.2 percentage points higher for a patient with a higher edu-
cation (relative to a patient with a lower education). The diﬀerence fell to 1.2
percentage points during the post-reform period, 1987-2000 (see upper panel
columns (3) and (4)). A similar pattern was also found for survival (see lower
panel columns (3) and (4)). Before the opening of a regional cancer ward, the
diﬀerence in survival probabilities between patients with higher and lower ed-
ucation was 7.2 percentage points, compared to 3.4 after the opening. This
diﬀerence is substantial. To provide a perspective, overall survival probabil-
ity increased from 0.43 to 0.59 from 1980 to 2000, corresponding to an annual
increase of 0.8 percentage points. If all the educational inequalities were due
to diﬀerences in treatment, the diﬀerence in survival before the reform corre-
sponded to nine years of progress in cancer treatment (assuming that all changes
in cancer survival rates are due to better treatment).
In the Northern health region, the diﬀerences in both survival and transfer
probabilities for patients with a higher education (relative to patients with a
lower education) was highest in the post-reform period (columns (5) and (6)).
20Unfortunately, we have too few observations in the pre-reform period to conduct a mean-
ingful statistical analysis based on patients' type of education.
21TheWestern region is assigned the same pre-reform and post-reform periods as the Central
region.
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The point estimates for the pre-reform period are not statistically signiﬁcant.
In the Western health region, which had a regional cancer ward during the
entire period under consideration, the diﬀerence in transfer probability between
education groups was also highest in the period 1980-1986. However, the reverse
was true for the diﬀerence in survival probabilities, which indicates a general
compression of inequalities in cancer survival over time in Norway.
Table 2 reports results based on the sample of patients residing in the
counties where the university hospitals are located (Troms, Sør-Trøndelag and
Hordaland). The results do not change much for the Central and Western re-
gions when the counties furthest from the university hospitals are excluded.
For the Northern region, on the other hand, the estimated eﬀect of education
becomes considerably smaller in the post-reform period for both transfer and
survival compared to the baseline analysis.
In summary, after the opening of regional cancer wards, the proportion of
cancer patients receiving treatment at the national hospitals in Oslo fell dramat-
ically. Moreover, the fall in the transfer rate was relatively steeper for patients
with higher education than for patients with lower education (especially when
focusing on the county in which the regional cancer ward is located). At the
same time, we also saw a decline in the diﬀerence in the survival probability be-
tween patients with higher and lower education. Taken together, these ﬁndings
indicate that the newly opened regional cancer wards may have been of lower
quality than the wards at the well-established hospitals in Oslo, and that access
to or utilization of specialized treatment may in part explain why patients with
higher education survived cancer to a greater extent than patients with a lower
education. We explore this in more detail in the next section.
4 The eﬀect of specialized treatment on overall
cancer survival
The opening of regional cancer wards at the teaching hospitals in Tromsø
(Northern region) and Trondheim (Central region) in the 1980s led to sudden
and large drops in transfer probabilities from the Northern and Central health
regions. At the same time, the transfer probability in the Western health re-
gion remained almost unchanged (recall Figure 2). This motivates the following
diﬀerence-in-diﬀerence (DiD) speciﬁcation:
17
surijt+5 = CN it + postjt + ψ(CN it ∗ postjt) +Xiν + θj + dt + uijt (1)
surijt+5 is a dummy variable that equals one if patient i in county j was still
alive ﬁve years after being diagnosed with cancer, CNit is a dummy variable
taking the value one if the patient was resident in the Central or Northern health
region at the time of diagnosis (the `treatment group') and zero if the patient
was resident in the Western health region (the `comparison group'), while, postjt
is a dummy variable taking the value one if diagnosis year ≥ the year of the
opening of the regional cancer ward (1985 for the Northern and 1987 for the
Central region), and zero otherwise. The opening of regional wards may, in
principle, have aﬀected the quality of care received by patients residing in the
Oslo region.22 For this reason we do not include patients from this region in
our comparison group.
Our parameter of interest is the diﬀerences-in-diﬀerences parameter ψ. As
discussed above, the care provided at newly opened cancer wards may have been
of lower quality than the care provided at the well-established national hospitals,
especially during the period shortly after establishment. If this was the case,
we should expect ψ < 0. To account for such temporary start-up eﬀects, we
allow for diﬀerent eﬀects in the short and long run and provide separate results
for the ﬁrst ﬁve years after the opening of a regional cancer ward (post1jt)
and the succeeding period (post2jt).
23 Furthermore, Xi is a vector of observed
characteristics of the patient/tumor (such as type of cancer (ICD10), stage, age
at diagnosis, gender and education), whereas θj and dt are county and year of
diagnosis dummies. Finally, uijt is an error term. Since patients living in the
same municipality share primary health care oﬀered by general practitioners,
we allow for arbitrary correlation in error terms within the 262 (residential)
municipalities (at the time of diagnosis) by clustering the standard errors at
this level. 24
22In practice, the opening of new regional cancer wards could have aﬀected the quality of
care also in Oslo, for instance through increased capacity at the national hospitals as fewer
transfers were made from regions outside this area. When including patients residing in the
Oslo region in our comparison group the point estimates decrease a bit, but remain statistically
signiﬁcant.
23Post1 = 1987-1991 for the Central region and 1985-1989 for the Northern region. Post2
= 1992-2000 for the Central region and 1990-2000 for the Northern region.
24The clusters are based on the municipality structure existing at the end of our sample
period (the year 2000). We are left with 262 clusters after the Oslo region has been excluded.
The total number of municipalities existing in 2000 is 435.
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Table 3 reports the results from estimating equation (1). It shows that the
relative prospects for surviving cancer deteriorated substantially for patients
when new wards were established in their region. When regional cancer wards
were established in the Central and Northern regions, the survival probability
declined by 1.6 percentage points for patients residing in those regions compared
to those living in the Western region. The eﬀect is statistically signiﬁcant at the
one percent level (see column (1)). The eﬀect does not seem to be transitory, i.e.,
it is present both in the ﬁrst ﬁve years after the opening (post1) and thereafter
(post2) (see column 2).
In the Northern and Central health regions, the opening of the regional
wards reduced the rate at which patients were transferred to Oslo with about
20 percentage points (cf. Figure 2).25 In the terminology of Imbens and Angrist
(1994), we can label patients receiving treatment (only) at regional rather than
national hospitals as compliers. Assuming that the entire population level
treatment eﬀect is due to patients complying with the reform, i.e. patients
receiving treatment (only) at regional rather than national hospitals, the average
individual-level treatment eﬀect is about 8 percentage points (1.6 * 5) for the
compliant subpopulation.26 Our results therefore suggest that the quality of care
provided by the national hospitals was considerably higher than the quality of
care at the regional wards.
As already discussed, the establishment of regional cancer wards may have
been of particular relevance to those residing close to the university hospitals
(due to long travel distances, especially in the North). In order to take this into
account, we also conducted separate analyses for the counties where the univer-
sity hospitals are located (Troms, Sør-Trøndelag and Hordaland). The results,
which are presented in columns (3) and (4), show that the point estimates
increase slightly relative to column (2), indicating an average individual-level
treatment eﬀect of about ten percentage points for the compliant subpopula-
tion.27 Even though the sample is reduced by 60%, the eﬀect is statistically
signiﬁcant for both post-reform periods at the ﬁve percent level. A relative de-
25The regression adjusted compliance rate is 18.5 percentage points.
26Note that this assumption may fail for two reasons. First, even after the establishment
of the regional wards some patients (about ten percent) were still transferred to Oslo. We do
not know the extent to which these patients also received treatment at regional hospitals. If
this group of patients received more treatment regionally than nationally as a consequence of
the hospital reform they may also have contributed to the population-level average treatment
eﬀect. Second, both before and after the hospital reforms a majority of patients were treated
only regionally. If the hospital reforms changed the quality of regional care for this group of
patients they may also have contributed to the population-level average treatment eﬀect.
27The regression adjusted compliance rate is 23.4 percentage points.
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cline in cancer survival of more than two percentage points is substantial, when
we take into account that the overall survival probability was around 50%. It
strongly suggests that the treatment received by patients from the counties of
Sør-Trøndelag and Troms deteriorated relative to national best practice stan-
dards after the establishment of the new wards.
As the treatment is provided at the regional level, this would be the ideal
level of clustering. However, with only three clusters this will not provide reli-
able inference. An intermediate solution is to allow for correlation in the error
terms at the local hospital catchment area as they represent a more conservative
clustering level than the residential municipalities. One drawback is, however,
that there are only 29 hospital catchment areas (after excluding the Oslo re-
gion) which is below the benchmark of 42 suggested by Angrist and Pischke
(2010). As a supplement to our municipality clustered standard errors we fol-
low Cameron, Gelbach and Miller (2008) and apply (wild) bootstrap resampling
methods when clustering at the hospital catchment area level. This is a com-
mon method in the case of few clusters (Angrist and Pischke, 2010). Using this
method the point estimate in the main speciﬁcation (column (1)) is statistically
signiﬁcant at the ten percent level (p= 0.076). When restricting the analysis
to counties with a university hospital (and only 11 clusters) the eﬀect is not
statistically signiﬁcant at conventional levels (p=0.129).
In a diﬀerences-in-diﬀerences research design, it is always a concern that
the parameter estimate of interest may be biased by diﬀerential time trends.
If characteristics aﬀecting cancer survival but not controlled for in our analysis
changed over time but diﬀerently in the regions studied, this could bias our
estimates. To check the robustness of our results in this respect, we estimate
year-speciﬁc DiD estimates, which are shown in Figure 7. It is evident that
the survival rate in the Northern health region started to deviate the year after
the regional cancer ward opened. This eﬀect is also visible in the raw data
(recall Figure 3). The pattern is less clear for the Central region, although
point estimates are also negative here for the period 1989-91 compared to the
period before the establishment of a regional cancer ward. Importantly, there
is no trace of any 'reform' eﬀect prior to the actual reform. The results are
reported in more detail in Appendix Table A.2.
Another concern is that the opening of regional cancer wards also changed
the (unobserved) composition of the cancer patients, which could potentially
bias our results. Figures 4 and 5, which document an equal trend in both
cancer incidences and stage at diagnosis in the Western, Central and Northern
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Figure 7: Year-speciﬁc DiD estimates, ﬁve-year survival probabilities
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Note: The ﬁrst vertical lines indicate the opening of the regional cancer wards.
The second vertical lines indicate when transfer rates reached the same level as
that of the Western region.
health regions, suggest, however, that such compositional eﬀects are not driving
our results.
According to national guidelines, certain rare cancer forms would continue
to be treated at highly specialized hospitals in the Oslo region, also after the
opening of the regional cancer wards (see Appendix Table A.3). Examples of
such cancer forms include most bone cancer forms, many of the head-and-neck
cancer forms, many of the central nervous system (CNS) tumors, and most soft-
tissue sarcomas. As a robustness check, we limit our analysis to only include
the four most common cancer types in our cohort (colorectal, lung, breast, and
prostate cancer). Appendix Table A.4 shows the results based on the inclusion of
these four cancer types only. The results are basically similar to those reported
in Table 3.
Overall, the results consistently show that the establishment of regional can-
cer wards had a negative eﬀect on cancer survival. The results are thus infor-
mative about the quality of care provided by the highly specialized national
hospitals located in Oslo.
5 The eﬀect of specialized treatment on educa-
tional inequalities
As already documented in Tables 1 and 2, the diﬀerence in both transfer and
survival probability between patients with higher and lower education appears
to have decreased after the opening of the regional cancer wards. To investigate
22
this pattern in more detail, we estimate the following diﬀerences-in-diﬀerences-
in-diﬀerences (DiDiD) speciﬁcation:
surijt+5 = CNit+postjt+θEdi+ψ(CNit ∗postjt)+µ(Edi ∗postjt ∗CNit) (2)
+ρ(Edi ∗ postjt) + pi(CNit ∗ Edi) +Xiν + θ∗j + d∗t + u∗ijt
As in equation (1), the parameter ψ measures the average eﬀect of regional
cancer treatment on survival. The interaction terms between higher education,
Edi, the region dummy CNi and the decentralization dummy postjt are new in
equation (2) compared to equation (1).
The new parameter of interest is the parameter µ. A negative µ implies
that educational inequalities in survival probabilities fell after the opening of
regional cancer wards. The total eﬀect of restricting access to treatment in Oslo
for a patient with a higher education is ψ+ µ, while it is ψ for a patient with a
lower education.
The DiDiD estimates are presented in Table 4. The results clearly indicate
that it was the highly educated who were aﬀected most strongly by the reform.
All speciﬁcations indicate a decrease in the diﬀerences in survival rates of about
four percentage points, e.g., in column (1), where the decline for those with
lower education was 1.4 percentage points, whereas it was 5.8 percentage points
for the highly educated. The eﬀect is statistically signiﬁcant at the ﬁve percent
level when conducting the analysis at health region level (column (1)). When
applying wild bootstrap resampling methods the DiDiD estimate is statistically
signiﬁcantly diﬀerent from zero (p=0.001), whereas the DiD estimate is not
(p=0.13).
When we split the post-reform period into two, we ﬁnd statistially signiﬁcant
eﬀects of a similar magnitude for both periods. At the county level, the point
estimates are statistically insigniﬁcant, but similar in magnitude to the baseline
analysis.28
As in the analysis in the previous section, diﬀerent time trends in the ed-
ucational composition of the treatment and control groups may give grounds
for concern. In Appendix Figure A.3, we report the trend in the proportion of
28Appendix Table A.5 shows the results from including only the four most common cancer
types. The results are basically similar to those reported in Table 4.
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the whole population (between 16 and 75 years) with a higher education sep-
arately for the diﬀerent regions.29 As the trend is very similar across regions,
compositional eﬀects in education are unlikely to drive our results.
Previous research has shown that individuals with a lower education also
tend to suﬀer from other serious diseases and therefore receive diﬀerent types of
treatment for such co-morbidities (Aarts et al 2013). This may further necessi-
tate modiﬁcations in the cancer treatment protocol. Unfortunately, we do not
have information about such co-morbidities. However, given that the trend in
such co-morbidities is likely to be the same in the treatment and control regions,
this should not be a source of bias in our research design.
All in all, a very clear pattern emerges from the results reported in this
section. Diﬀerences in survival rates with respect to education fell substantially
after the opening of the new regional cancer wards. As we documented earlier,
this went hand in hand with a decline in the transfer probability, which was
most pronounced for the highly educated. The results strongly suggest that
the relative fall in survival probability for the highly educated was the result of
a reduction in the pre-reform advantage they had in terms of access to highly
specialized treatment at the national hospitals.
6 Conclusion
The point of departure for this paper is the well-known fact that highly educated
individuals survive cancer to a greater extent than others. We test the hypothe-
sis that this may in part be driven by highly educated individuals having better
access to, or to a greater extent utilizing, specialized cancer treatment. In a
welfare state with strong egalitarian preferences and a publicly ﬁnanced health
care system, diﬀerential use of selected treatment options could be seen as an
indication that the system is functioning sub-optimally.
We document that, among cancer patients residing outside the Oslo region,
highly educated patients, and doctors in particular, are more likely than other
patients to be transferred to the two specialized hospitals in the capital. Since
these hospitals are likely to oﬀer more advanced treatment provided by a highly
skilled staﬀ, such transfers would also be expected to increase survival proba-
bilites. This is hard to investigate empirically, since patients who suﬀer from the
most severe diseases are the ones that are most likely to be transferred. How-
29The ﬁgure is constructed using additional data collected at the regional level from the
Norwegian Social Science Data Service (NSD).
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ever, we ﬁnd that the educational inequalities in transfer probabilities become
more pronounced when we condition on a rich set of disease characteristics. It
is also striking that patients who have a medical education are the ones with the
highest transfer and survival probabilities conditional on disease characteristics.
It is possible, of course, that unobserved patient and disease characteristics
vary systematically diﬀerently across types and levels of education compared
to the observed characteristics, but we ﬁnd this unlikely. While these ﬁndings
in themselves suggest that educated patients utilize specialized treatment to a
greater extent, they do not establish that this explains (part of) the educational
inequality in survival.
To do this, we need an exogenous source of variation in access to specialized
treatment. Our empirical approach was to utilize reforms in cancer treatment
in Norway in the 1980s, when specialized cancer wards were established in the
Central and Northern health regions. As a consequence of this, the proportion
of patients transferred to the national specialized hospitals fell dramatically
because of increased regional capacity and more explicit transfer regulations. We
ﬁnd that the reforms had a negative eﬀect on the survival probability for patients
residing in the regions where the new wards were established (i.e., survival
improved less than in other regions). This was particularly true for highly
educated patients. These results indicate that the initial quality of treatment
or care at the new regional wards may have been lower than that oﬀered at the
national hospitals, but also that the reforms reduced the educational inequalities
in cancer survival. Taken at face value, the point estimates suggest that a
substantial part of the educational diﬀerence in cancer survival in these regions
was due to diﬀerences in access to and utilization of specialized treatment at
the national level hospitals.
A point of departure for this study was the educational gradient in cancer
survival, which may be the result of many complex mechanisms, which are
not all related to treatment. What do our quasi-experimental results suggest
about the determinants of cancer survival, or the structural parameters of a
health production function? As mentioned in the introduction, one mechanism
explored by Grossman (1972) is that education aﬀects health directly because
educated individuals use available inputs more eﬃciently. A typical ﬁnding by
previous studies is that more educated individuals make better use of health-
relevant information available to all. Our ﬁnding that educated individuals made
more use of high quality health inputs (transfer to the specialized hospitals) is a
similar mechanism, but goes one step further. It implies not only asymmetric use
26
of information, but also asymmetric use of an input with restricted access. In our
case, treatment was not rationed through the price mechanism, but through an
allocation procedure that allowed for some discretion. This discretion appears
to have favored the highly educated, who gained access to more productive
inputs (specialized treatment), possibly using an information or competency
advantage.
It is not surprising that a fully privatized health care system can produce
social inequalities. Our results suggest that even within in a public health
care system, socioeconomic inequalities in cancer survival can arise when health
personnel have substantial discretion in referral practices. They also highlight
that the organization of health care may involve a painful trade-oﬀ between
proximity and quality of treatment.
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A Appendix
Figure A.1: Five-year survival rates by year of diagnosis and health region, Oslo
region included
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Note: The ﬁgures display the survival rate by health region. A patient is deﬁned
as having survived cancer if he/she is alive ﬁve years after cancer diagnosis.
Figure A.2: Cancer incidence by health region, Oslo region included
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Note: The ﬁgure display the number of incident cancers by health region.
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Figure A.3: Fraction of the population (between 16 and 75 years) with high
education by health region.
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Note: This ﬁgure is constructed using separate regional level data from the
Norwegian Social Science Data Service (NSD)
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Table A.1: Summary statistics of the variables used in the analyses
Mean St.dev Min Max
Survival ﬁve years after diagnosis 0.502 0.500 0 1
Transfer to the Oslo region 0.113 0.317 0 1
Age at diagnosis 61.4 11.02 30 75
Year of diagnosis 1991 6.07 1980 2000
University level education (15 years or more) 0.100 0.300 0 1
Gender dummy (1=Female, 0=Male) 0.470 0.500 0 1
Stage at diagnosis
Localized 0.437 0.500 0 1
Regional spread 0.172 0.377 0 1
Distant spread 0.195 0.396 0 1
Unknown spread 0.197 0.398 0 1
Cancer type (encoded by icd-10)
Head and neck, incl eye (C00-14, C30-32, C69) 0.033 0.180 0 1
Esophageal (C15) 0.007 0.081 0 1
Stomach (C16) 0.045 0.207 0 1
Small intestine (C17) 0.003 0.059 0 1
Colorectal (C18-C21) 0.141 0.348 0 1
Hepatic/biliary (C22-C24) 0.010 0.101 0 1
Pancreatic (C25) 0.030 0.171 0 1
Lung (C34, C39) 0.099 0.299 0 1
Endocrine (C37, C73-75) 0.019 0.135 0 1
Bone (C40-C41) 0.002 0.040 0 1
Skin (C43-44) 0.067 0.250 0 1
Soft tissue (C45-49) 0.004 0.061 0 1
Peritoneal (C48) 0.002 0.041 0 1
Breast (C50) 0.122 0.327 0 1
Cervical/uterine (C53-55) 0.049 0.216 0 1
Ovarian (C56) 0.028 0.165 0 1
Other female gyn. (C51-52, C57-58) 0.004 0.063 0 1
Prostate (C61) 0.107 0.309 0 1
Testicular (C62) 0.011 0.102 0 1
Penile/other male genital (C60, C63) 0.002 0.040 0 1
Renal/bladder (C64-68) 0.082 0.274 0 1
CNS (C69-72, D32-33) 0.035 0.183 0 1
Leukemia/lymphoma (C81-85, C90-95) 0.070 0.255 0 1
Other or unspeciﬁed (C26, C38, C76-80, C86-88, C96-97) 0.028 0.166 0 1
No of observations = 99,739.
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Table A.2: The eﬀect of hospital reforms on survival ﬁve years after diagnosis,
year-speciﬁc DiD estimates, separate results for the Northern and Central health
region
(1) (2)
Treatment -0.007 (0.018) 0.017 (0.017)
Treatment*Year
(1980=ref)
1981 -0.020 (0.027) -0.008 (0.027)
1982 0.016 (0.020) 0.005 (0.019)
1983 0.012 (0.023) 0.019 (0.019)
1984 0.016 (0.022) 0.010 (0.024)
1985 -0.003 (0.022) -0.005 (0.023)
1986 -0.017 (0.024) -0.012 (0.021)
1987 -0.037 (0.022)* -0.001 (0.021)
1988 -0.038 (0.019)** -0.001 (0.020)
1989 -0.047 (0.021)** -0.029 (0.021)
1990 -0.050 (0.022)** -0.020 (0.019)
1991 -0.009 (0.023) -0.024 (0.018)
1992 -0.030 (0.024) -0.011 (0.022)
1993 -0.022 (0.021) 0.023 (0.018)
1994 -0.022 (0.023) -0.015 (0.024)
1995 -0.030 (0.021) 0.008 (0.020)
1996 -0.030 (0.021) -0.009 (0.020)
1997 -0.044 (0.021)** -0.013 (0.019)
1998 -0.063 (0.019)** -0.014 (0.020)
1999 -0.049 (0.022)** -0.018 (0.019)
2000 -0.021 (0.017) -0.014 (0.018)
Dep var (mean) 0.501 0.512
Treatment North Central
Control West West
No of clusters 175 172
R-square 0.3629 0.3606
No of obs 67378 76654
Note: The dependent variable is a dummy variable that equals one if the pa-
tient is alive ﬁve years after diagnosis. Standard errors within brackets are
heteroscedastic robust and corrected for clustering at the (residential) munici-
pality at the time of diagnosis. Included in all speciﬁcations are a constant term,
dummy variables for educational level, gender, age at diagnosis, disease charac-
teristics, year of diagnosis and county of residence. */**/*** denote statistical
signiﬁcance at the 10/5/1 percent levels, respectively.
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Table A.3: Transfer proportions before and after the opening of regional cancer
hospitals
Central North
ICD10 0 1 0 1
Head and neck 0.688 0.234 0.724 0.366
Oesophageal 0.356 0.055 0.568 0.057
Stomach 0.031 0.019 0.032 0.025
Small intestine 0.125 0.150 0.182 0.140
Colorectal 0.103 0.036 0.136 0.055
Hepatic/biliary 0.107 0.065 0.125 0.071
Pancreatic 0.042 0.018 0.069 0.025
Lung 0.457 0.041 0.584 0.078
Endocrine 0.333 0.088 0.487 0.186
Bone 0.667 0.429 0.667 0.692
Skin 0.120 0.028 0.228 0.067
Soft tissue 0.520 0.159 0.828 0.391
Peritoneal 0.462 0.170 0.200 0.225
Breast 0.226 0.035 0.353 0.083
Cervical/uterine 0.903 0.180 0.909 0.295
Ovarian 0.717 0.191 0.819 0.262
Other female gyn. 0.776 0.161 0.714 0.299
Prostate 0.062 0.013 0.133 0.032
Testicular 0.767 0.074 0.902 0.159
Penile/other male genital 0.467 0.061 0.429 0.118
Renal/bladder 0.232 0.035 0.262 0.061
CNS 0.452 0.085 0.741 0.177
Leukemia/lymphoma 0.262 0.050 0.289 0.089
Other or unspeciﬁed 0.170 0.031 0.227 0.077
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